A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,182 shares of VNDA stock, worth $157,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,182
Previous 29,286 6.47%
Holding current value
$157,469
Previous $165,000 11.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.61 - $6.34 $8,740 - $12,020
1,896 Added 6.47%
31,182 $146,000
Q2 2024

Aug 14, 2024

BUY
$3.91 - $6.5 $114,508 - $190,359
29,286 New
29,286 $165,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $286M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.